Christopher Gibson's Securities Transactions in Recursion Pharmaceuticals, Inc.

The filing details the securities transactions of Christopher Gibson, an officer and director of Recursion Pharmaceuticals, Inc. The transactions include the sale of Class A shares acquired as Founders Shares. The filing notes that Gibson plans to sell 100,000 Class A shares on or around October 23, 2025, with an aggregate market value of $570,000. Additionally, the filing reports multiple sales of Class A shares by Gibson and related entities over the past three months, totaling significant amounts. The transactions were executed through Fidelity Brokerage Services LLC, with sales occurring on various dates in August, September, and October 2025. The filing also mentions that some sales were made through the Gibson Family Trust and Lahwran-3 Llc accounts, where Gibson holds trustee and authorized individual roles, respectively.